|
Originally published In Press as doi:10.1074/jbc.M502068200 on May 24, 2005
J. Biol. Chem., Vol. 280, Issue 29, 27044-27055, July 22, 2005
Characterization of the Interaction between Tumor Necrosis Factor-stimulated Gene-6 and Heparin
IMPLICATIONS FOR THE INHIBITION OF PLASMIN IN EXTRACELLULAR MATRIX MICROENVIRONMENTS*
David J. Mahoney ,
Barbara Mulloy¶,
Mark J. Forster¶,
Charles D. Blundell||**,
Eric Fries ,
Caroline M Milner, Supported by a Nuffield Foundation Oliver Bird Fellowship (RHE/00045/G)   , and
Anthony J. Day ¶¶
From the
Medical Research Council Immunochemistry Unit and the ||Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, United Kingdom, the ¶National Institute for Biological Standards and Control, Blanche Lane, South Mimms, Potters Bar, EN6 3QG, Hertfordshire, United Kingdom, and the  Department of Medical Biochemistry and Microbiology, Uppsala University, S-751 23 Uppsala, Sweden
TSG-6, the secreted product of tumor necrosis factor-stimulated gene-6, is not constitutively expressed but is up-regulated in various cell-types during inflammatory and inflammation-like processes. The mature protein is comprised largely of contiguous Link and CUB modules, the former binding several matrix components such as hyaluronan (HA) and aggrecan. Here we show that this domain can also associate with the glycosaminoglycan heparin/heparan sulfate. Docking predictions and site-directed mutagenesis demonstrate that this occurs at a site distinct from the HA binding surface and is likely to involve extensive electrostatic contacts. Despite these glycosaminoglycans binding to non-overlapping sites on the Link module, the interaction of heparin can inhibit subsequent binding to HA, and it is possible that this occurs via an allosteric mechanism. We also show that heparin can modify another property of the Link module, i.e. its potentiation of the anti-plasmin activity of inter- -inhibitor (I I). Experiments using the purified components of I I indicate that TSG-6 only binds to the bikunin chain and that this is at a site on the Link module that overlaps the HA binding surface. The association of heparin with the Link module significantly increases the anti-plasmin activity of the TSG-6·I I complex. Changes in plasmin activity have been observed previously at sites of TSG-6 expression, and the results presented here suggest that TSG-6 is likely to contribute to matrix remodeling, at least in part, through down-regulation of the protease network, especially in locations containing heparin/heparan sulfate proteoglycans. The differential effects of HA and heparin on TSG-6 function provide a mechanism for its regulation and functional partitioning in particular tissue microenvironments.
Received for publication, February 23, 2005
, and in revised form, May 2, 2005.
* This work was supported in part by the United Kingdom Medical Research Council and Arthritis Research Campaign (ARC). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Supported by the ARC (Grants M0621, M0625, 16119, and 16539).
** Supported by an ARC PhD studentship (Grant D0569).
 To whom correspondence may be addressed. Tel.: 44-1865-275348; Fax: 44-1865-275729; E-mail: caroline.milner{at}bioch.ox.ac.uk. ¶¶ To whom correspondence may be addressed. Tel.: 44-1865-275349; Fax: 44-1865-275729; E-mail: tony.day{at}bioch.ox.ac.uk.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. A. Deakin, B. S. Blaum, J. T. Gallagher, D. Uhrin, and M. Lyon
The Binding Properties of Minimal Oligosaccharides Reveal a Common Heparan Sulfate/Dermatan Sulfate-binding Site in Hepatocyte Growth Factor/Scatter Factor That Can Accommodate a Wide Variety of Sulfation Patterns
J. Biol. Chem.,
March 6, 2009;
284(10):
6311 - 6321.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. W. Sanggaard, C. S. Sonne-Schmidt, T. P. Krogager, T. Kristensen, H.-G. Wisniewski, I. B. Thogersen, and J. J. Enghild
TSG-6 Transfers Proteins between Glycosaminoglycans via a Ser28-mediated Covalent Catalytic Mechanism
J. Biol. Chem.,
December 5, 2008;
283(49):
33919 - 33926.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. C. Heng, P. M. Gribbon, A. J. Day, and T. E. Hardingham
Hyaluronan Binding to Link Module of TSG-6 and to G1 Domain of Aggrecan Is Differently Regulated by pH
J. Biol. Chem.,
November 21, 2008;
283(47):
32294 - 32301.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Mahoney, K. Mikecz, T. Ali, G. Mabilleau, D. Benayahu, A. Plaas, C. M. Milner, A. J. Day, and A. Sabokbar
TSG-6 Regulates Bone Remodeling through Inhibition of Osteoblastogenesis and Osteoclast Activation
J. Biol. Chem.,
September 19, 2008;
283(38):
25952 - 25962.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. N. Harris and P. H. Weigel
The ligand-binding profile of HARE: hyaluronan and chondroitin sulfates A, C, and D bind to overlapping sites distinct from the sites for heparin, acetylated low-density lipoprotein, dermatan sulfate, and CS-E
Glycobiology,
August 1, 2008;
18(8):
638 - 648.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. W. Sanggaard, C. S. Sonne-Schmidt, T. P. Krogager, K. A. Lorentzen, H.-G. Wisniewski, I. B. Thogersen, and J. J. Enghild
The Transfer of Heavy Chains from Bikunin Proteins to Hyaluronan Requires Both TSG-6 and HC2
J. Biol. Chem.,
July 4, 2008;
283(27):
18530 - 18537.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. S Mummery, B. Mulloy, and C. C Rider
The binding of human betacellulin to heparin, heparan sulfate and related polysaccharides
Glycobiology,
October 1, 2007;
17(10):
1094 - 1103.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. D. Blundell, D. J. Mahoney, M. R. Cordell, A. Almond, J. D. Kahmann, A. Perczel, J. D. Taylor, I. D. Campbell, and A. J. Day
Determining the Molecular Basis for the pH-dependent Interaction between the Link Module of Human TSG-6 and Hyaluronan
J. Biol. Chem.,
April 27, 2007;
282(17):
12976 - 12988.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Forteza, S. M. Casalino-Matsuda, M. E. Monzon, E. Fries, M. S. Rugg, C. M. Milner, and A. J. Day
TSG-6 Potentiates the Antitissue Kallikrein Activity of Inter-{alpha}-inhibitor through Bikunin Release
Am. J. Respir. Cell Mol. Biol.,
January 1, 2007;
36(1):
20 - 31.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Clark, V. A. Higman, B. Mulloy, S. J. Perkins, S. M. Lea, R. B. Sim, and A. J. Day
His-384 Allotypic Variant of Factor H Associated with Age-related Macular Degeneration Has Different Heparin Binding Properties from the Non-disease-associated Form
J. Biol. Chem.,
August 25, 2006;
281(34):
24713 - 24720.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Al'Qteishat, J. Gaffney, J. Krupinski, F. Rubio, D. West, S. Kumar, P. Kumar, N. Mitsios, and M. Slevin
Changes in hyaluronan production and metabolism following ischaemic stroke in man
Brain,
August 1, 2006;
129(8):
2158 - 2176.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Kuznetsova, A. J. Day, D. J. Mahoney, M. S. Rugg, D. F. Mosher, and D. D. Roberts
The N-terminal Module of Thrombospondin-1 Interacts with the Link Domain of TSG-6 and Enhances Its Covalent Association with the Heavy Chains of Inter-{alpha}-trypsin Inhibitor
J. Biol. Chem.,
September 2, 2005;
280(35):
30899 - 30908.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|